TP53 and cancer: By summarizing the p53-R175H gain-of-functions reported by different groups, p53-R175H and other p53 hotspot mutations were found to contribute to tumor development by promoting cancer cell proliferation, migration, invasion, initiation, metabolic reprogramming, angiogenesis, and conferring drug resistance to cancer cells (Table 2).